FDA Inspection 1119027 — Millipore (U.K.) Ltd.

Millipore (U.K.) Ltd. — FEI 3002638287

The FDA completed an inspection of Millipore (U.K.) Ltd. on February 27, 2020 in Livingston. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 27, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston (United Kingdom)

Citations

IDCFRDescription
907821 CFR 600.12(a)Maintenance - tracing
932621 CFR 610.1Tests prior to release